Location History:
- San Francisco, CA (US) (2021)
- Menlo Park, CA (US) (2019 - 2023)
Company Filing History:
2 out of 90 
1 out of 19 
1 out of 15,471 
Years Active: 2019-2023
Title: Anke Meyer-Franke: Innovator in Fibrin Activity Research
Introduction
Anke Meyer-Franke is a prominent inventor based in San Francisco, CA. She has made significant contributions to the field of biomedical research, particularly in the area of fibrin activity. With a total of 3 patents, her work focuses on developing innovative methods and compositions for in vitro assays.
Latest Patents
Meyer-Franke's latest patents include groundbreaking inventions such as "Compositions and methods for in vitro assays of fibrin activity." This invention provides compositions that exhibit in vivo activity of fibrin in an in vitro setting. It includes methods for producing these compositions and using them in assays. The compositions are designed to bind with high affinity to fibrin receptors and activate cell-signaling systems similar to those observed in vivo. Additionally, her patent on "In vitro assays for inhibition of microglial activation" offers cell-based assays for identifying therapeutic agents that can inhibit microglial activation in response to various ligands.
Career Highlights
Throughout her career, Anke Meyer-Franke has worked with esteemed organizations such as the J. David Gladstone Institutes. Her research has significantly advanced the understanding of fibrin's role in various biological processes.
Collaborations
Meyer-Franke has collaborated with notable colleagues, including Katerina Akassoglou and Jae Kyu Ryu, contributing to a rich exchange of ideas and research advancements.
Conclusion
Anke Meyer-Franke's innovative work in fibrin activity research has led to valuable patents that enhance our understanding of cellular processes. Her contributions continue to impact the field of biomedical research significantly.